LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Swabs Compared for Pediatric Enteropathogens

By LabMedica International staff writers
Posted on 25 Oct 2017
Image: The xTAG Gastrointestinal Pathogen Panel is a multiplexed nucleic acid test intended for the simultaneous qualitative detection and identification of multiple viral, parasitic, and bacterial nucleic acids in human stools (Photo courtesy of Luminex).
Image: The xTAG Gastrointestinal Pathogen Panel is a multiplexed nucleic acid test intended for the simultaneous qualitative detection and identification of multiple viral, parasitic, and bacterial nucleic acids in human stools (Photo courtesy of Luminex).
Diarrheal stool samples are currently preferred for enteropathogen detection, but they are inconvenient to collect if they are not immediately available, leading to suboptimal return rates and delayed or missed diagnostic opportunities.

It is sometimes difficult to collect a sufficient fecal sample from pediatric patients, so a comparison of enteropathogen yields of rectal swabs and stool specimens in an outpatient cohort of children with diarrhea and/or vomiting has been conducted.

A team of scientists working with the University of Calgary (Calgary, AB, Canada) studied an outpatient cohort of children who were less than 18 years of age, with equal to or greater than three episodes of vomiting or diarrhea in 24 hours and with less than seven days of symptoms. The team attempted to collect rectal swabs and stool from all participants. Specimens were subjected to testing with the xTAG Gastrointestinal Pathogen Panel, an in-house 5-virus panel and bacterial culture. Primary outcomes were comparative (submitted paired specimens only) and overall (all specimens, unsubmitted specimens analyzed as negative) yields.

Of the 1,519 subjects enrolled, 1,147 (75.5%) and 1,514 (99.7%) provided stool and swab specimens, respectively. The proportions of specimens positive for any pathogen were 75.9% (871/1147) and 67.6% (1024/1514). Comparative yield adjusted odds ratio (OR) in stool relative to swabs were 1.24 and 1.76 in children with and without diarrhea at presentation, respectively. Overall concordance analysis yielded a kappa of 0.76. Paired positive viral specimens had a lower median cycle threshold value that is higher viral loads in stool samples compared with swabs for all viruses. In overall yield analysis, the proportions positive for a pathogen was 57.3% and 67.4% for stool and rectal swabs, respectively; unadjusted OR: 0.65 for stool relative to swab.

The authors concluded that rectal swabs should be performed when enteropathogen identification, and/or rapid detection, is needed, molecular diagnostic technology available, and stool not immediately available. The study was presented at the annual meeting of the Infectious Diseases Society of America (IDSA) held October 4-8, 2017, in San Diego, CA, USA.

Related Links:
University of Calgary

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Urine Chemistry Control
Dropper Urine Chemistry Control

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more